Philadelphia cell therapy startup Century Therapeutics announced Monday it was emerging from "stealth mode" with $250 million in financing commitments.
The funding commitments are from Bayer in Germany, Versant Ventures of San Francisco and Tokyo-based Fujifilm Cellular Dynamics Inc.
Century plans to use the proceeds to advance multiple programs covering potenital treatments for hematologic and solid malignancies into the clinic.
The company said its foundational technology is built on induced…
